Machine Learning

A native probiotic developed in Thailand is shown to reduce harmful toxins in kidney disease patients, offering a new, locally-tailored supportive therapy.

Former Biosynth CEO Dr. Urs Spitz joins Ribbon Bio, signaling a major push to commercialize its groundbreaking cell-free DNA synthesis platform.

A new report shows AI is elevating UK tech roles, not replacing them, while specialized skills command top global pay amid a persistent talent shortage.

Hemispherian launches a landmark trial for GLIX1, a first-in-class therapy aiming to selectively destroy glioblastoma cells where others have failed.

Configit's upcoming summit highlights how CLM provides the data foundation for manufacturers to master mass customization and successfully deploy AI.

As Hong Kong's ETF market booms, ETF365.com.hk launches to provide transparent data, comparisons, and reviews for the everyday retail investor.

A new alliance between Daiichi Sankyo and ATLATL aims to leverage a unique 'Super Server' model to fast-track novel therapies from Asia to the world.

EDERRA's new partnership with Cepham signals a shift in wellness, blending brand transparency with manufacturing science to lead the functional food market.

The race for AI supremacy pushed semiconductor equipment sales to an unprecedented high in 2025, as Asia widens its manufacturing investment lead over the West.

A new certification for AI-guided cardiac ultrasound seeks to solve the training and trust gap, making crucial heart scans more accessible for frontline providers.

From knitting injuries to problems with in-laws, medical codes are a costly mess. AI is now untangling the $36 billion problem, one bizarre diagnosis at a time.

HCM giant Paylocity buys AI startup Grayscale, signaling a major push to automate high-volume hiring. But can it solve the efficiency puzzle without bias?

US firm SunHydrogen opens a Japan office led by a top researcher, aiming to scale its solar hydrogen tech in one of the world's leading clean energy markets.

After three rejections, Outlook Therapeutics escalates its fight for US approval of a key wet AMD drug, already sold in Europe. Will the FDA bend?

As AI drives DRAM costs to a breaking point, one startup's software uses AI to fight back, promising to slash server costs and expand memory capacity.

Miami startup Petwealth emerges from stealth with at-home PCR tests and key partnerships, aiming to revolutionize the $200B pet health industry.

The leading health system is deploying Midstream Health's AI agents to tackle operational costs and secure long-term financial sustainability.

Grön's new PIXLZ gummies blend Y2K nostalgia with advanced cannabis science, aiming to reprogram the edible experience with mode-based, sensory effects.

As AI chatbots transform how renters find apartments, one VC firm is betting on the startups that will help properties stay visible in a post-search world.

A new partnership between FarmRaise and Avalo aims to scale AI-driven cotton innovation, promising higher yields and less paperwork for growers.